Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway
Saptarshi Sinha, Subhajit Chatterjee, Subarno Paul, et al.
Experimental Cell Research (2022) Vol. 420, Iss. 1, pp. 113338-113338
Closed Access | Times Cited: 18

Showing 18 citing articles:

Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis
Rajalaxmi Pradhan, Subarno Paul, S. Acharya, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 125, pp. 109568-109568
Closed Access | Times Cited: 15
BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers
Anna P. Loboda, Leonid Adonin, Svetlana Zvereva, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4982-4982
Open Access | Times Cited: 18
Hyaluronic acid-empowered nanotheranostics in breast and lung cancers therapy
Fahad Alsaikhan
Environmental Research (2023) Vol. 237, pp. 116951-116951
Closed Access | Times Cited: 12
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation
Saptarshi Sinha, Subarno Paul, S. Acharya, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 4
Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between β-catenin and GLI-1 through p53-independent activation of p21
Subhasmita Bhal, Biswajit Das, Saptarshi Sinha, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access | Times Cited: 4
Polyphenols: Potential Applications in Cancer Therapy
María Oriol‐Caballo, Paz Moreno-Murciano, Rafael López‐Blanch, et al.
Molecular Nutrition & Food Research (2025)
Closed Access
Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
Subarno Paul, Subhajit Chatterjee, Saptarshi Sinha, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 999-1015
Closed Access | Times Cited: 9
Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300
Chinmay Das, Somya Ranjan Dash, Saptarshi Sinha, et al.
Medical Oncology (2023) Vol. 40, Iss. 12
Open Access | Times Cited: 8
The interlacing anticancer effect of pharmacologic ascorbate, chloroquine, and resveratrol
Kinga Makk‐Merczel, Dóra Varga, Péter Hajdinák, et al.
BioFactors (2024) Vol. 50, Iss. 5, pp. 980-996
Open Access | Times Cited: 2
Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells
Biswajit Das, Chinmayee Sethy, Subhajit Chatterjee, et al.
Journal of Cell Communication and Signaling (2023) Vol. 17, Iss. 4, pp. 1371-1388
Open Access | Times Cited: 5
Design, synthesis, and anticancer activity of some novel 1H-benzo[d]imidazole-5-carboxamide derivatives as fatty acid synthase inhibitors
Shailendra Singh, Subarno Paul, Natércia F. Brás, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106658-106658
Closed Access | Times Cited: 5
Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy
Mohsen Bagheri, Mohammad Arad Zandieh, Mahshid Daryab, et al.
Translational Oncology (2023) Vol. 39, pp. 101838-101838
Open Access | Times Cited: 5
Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents
Vajja Krishna Rao, Subarno Paul, Mitchell Gulkis, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 3, pp. 937-962
Closed Access | Times Cited: 1
Near Infrared-Responsive Quinacrine–Gold Hybrid Nanoparticles Deregulate HSP-70/P300-Mediated H3K14 Acetylation in ER/PR+ Breast Cancer Stem Cells
Somya Ranjan Dash, Chinmay Das, Biswajit Das, et al.
Nanomedicine (2024) Vol. 19, Iss. 7, pp. 581-596
Closed Access
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin
Chanchal Kiran Thakur, Fábio G. Martins, Chandrabose Karthikeyan, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 8
Open Access
Scaffold overlay of flavonoid-inspired molecules: Discovery of 2,3-diaryl-pyridopyrimidin-4-imine/ones as dual hTopo-II and tubulin targeting anticancer agents
Meenu Saini, Subarno Paul, Ayan Acharya, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107738-107738
Closed Access
Research Progress on the Molecular Mechanisms of Resveratrol in Breast Cancer
平 李
World Journal of Cancer Research (2024) Vol. 14, Iss. 04, pp. 155-165
Closed Access
Talazoparib enhances the Quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300
Chinmay Das, Somya Ranjan Dash, Saptarshi Sinha, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top